Life ScienceCompany
B. Braun Medical - Critical Cell Therapy Manufacturing Assets Ownership
Who owns B. Braun Medical - Critical Cell Therapy Manufacturing Assets?
B. Braun Medical - Critical Cell Therapy Manufacturing Assets is owned by Healiva SA. It was acquired on November 21, 2022.
B. Braun Medical - Critical Cell Therapy Manufacturing Assets Business Overview
Where is B. Braun Medical - Critical Cell Therapy Manufacturing Assets headquartered?
B. Braun Medical - Critical Cell Therapy Manufacturing Assets is headquartered in Switzerland.
What sector is B. Braun Medical - Critical Cell Therapy Manufacturing Assets in?
B. Braun Medical - Critical Cell Therapy Manufacturing Assets is a life science company.
Life Science M&A Summary in 2022
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2022. The largest life science acquisition in 2022 was Horizon Therapeutics Public Limited Company - which was acquired by Amgen for $27.8B.
Join Mergr to view all 293 acquisitions of life science companies in 2022, including 37 acquisitions by private equity firms, and 256 by strategics.